<?xml version='1.0' encoding='utf-8'?>
<document id="7780674"><sentence text="Efficacy and gastroduodenal safety of a fixed combination of diclofenac and misoprostol in the treatment of arthritis."><entity charOffset="61-71" id="DDI-PubMed.7780674.s1.e0" text="diclofenac" /><entity charOffset="76-87" id="DDI-PubMed.7780674.s1.e1" text="misoprostol" /><pair ddi="false" e1="DDI-PubMed.7780674.s1.e0" e2="DDI-PubMed.7780674.s1.e0" /><pair ddi="false" e1="DDI-PubMed.7780674.s1.e0" e2="DDI-PubMed.7780674.s1.e1" /></sentence><sentence text="Non-steroidal anti-inflammatory drugs (NSAIDs) are an effective therapy for the management of arthritis, but their use is restricted by the risk of gastrointestinal complications from NSAID-induced ulceration" /><sentence text=" The elderly, in particular, are vulnerable to such damage and complications" /><sentence text=" Misoprostol is the only cytoprotective drug found to be effective in the prevention of both gastric and duodenal ulcers associated with NSAIDs"><entity charOffset="1-12" id="DDI-PubMed.7780674.s4.e0" text="Misoprostol" /></sentence><sentence text=" A fixed-combination of diclofenac 50 mg/misoprostol 200 micrograms has been evaluated for efficacy and safety in the treatment of arthritis"><entity charOffset="24-34" id="DDI-PubMed.7780674.s5.e0" text="diclofenac" /><entity charOffset="41-52" id="DDI-PubMed.7780674.s5.e1" text="misoprostol" /><pair ddi="false" e1="DDI-PubMed.7780674.s5.e0" e2="DDI-PubMed.7780674.s5.e0" /><pair ddi="false" e1="DDI-PubMed.7780674.s5.e0" e2="DDI-PubMed.7780674.s5.e1" /></sentence><sentence text=" Pharmacokinetic studies of the fixed combination have found that no drug-drug interaction occurs between misoprostol and diclofenac after either single or multiple doses, and the bioavailability of misoprostol and diclofenac are comparable with that of misoprostol and diclofenac given alone"><entity charOffset="106-117" id="DDI-PubMed.7780674.s6.e0" text="misoprostol" /><entity charOffset="122-132" id="DDI-PubMed.7780674.s6.e1" text="diclofenac" /><entity charOffset="199-210" id="DDI-PubMed.7780674.s6.e2" text="misoprostol" /><entity charOffset="215-225" id="DDI-PubMed.7780674.s6.e3" text="diclofenac" /><entity charOffset="254-265" id="DDI-PubMed.7780674.s6.e4" text="misoprostol" /><entity charOffset="270-280" id="DDI-PubMed.7780674.s6.e5" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e0" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e1" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e0" e2="DDI-PubMed.7780674.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e1" e2="DDI-PubMed.7780674.s6.e1" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e1" e2="DDI-PubMed.7780674.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e1" e2="DDI-PubMed.7780674.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e1" e2="DDI-PubMed.7780674.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e1" e2="DDI-PubMed.7780674.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e2" e2="DDI-PubMed.7780674.s6.e2" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e2" e2="DDI-PubMed.7780674.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e2" e2="DDI-PubMed.7780674.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e2" e2="DDI-PubMed.7780674.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e3" e2="DDI-PubMed.7780674.s6.e3" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e3" e2="DDI-PubMed.7780674.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e3" e2="DDI-PubMed.7780674.s6.e5" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e4" e2="DDI-PubMed.7780674.s6.e4" /><pair ddi="false" e1="DDI-PubMed.7780674.s6.e4" e2="DDI-PubMed.7780674.s6.e5" /></sentence><sentence text=" This fixed combination was found to be equivalent to other NSAIDs in the control of symptoms and other parameters of arthritis" /><sentence text=" The fixed combination was generally well tolerated, although the occurrence of abdominal pain and diarrhoea was slightly more frequent than with other NSAIDs" /><sentence text=" This contrasts with a 2- to 3-fold reduction in the rate of gastroduodenal damage with the fixed combination compared with the rate associated with other NSAIDs" /><sentence text=" These results indicate that the diclofenac 50 mg/misoprostol 200 micrograms combination should be considered in preference to other NSAIDs when treating patients at risk of ulcer complications"><entity charOffset="33-43" id="DDI-PubMed.7780674.s10.e0" text="diclofenac" /><entity charOffset="50-61" id="DDI-PubMed.7780674.s10.e1" text="misoprostol" /><pair ddi="false" e1="DDI-PubMed.7780674.s10.e0" e2="DDI-PubMed.7780674.s10.e0" /><pair ddi="false" e1="DDI-PubMed.7780674.s10.e0" e2="DDI-PubMed.7780674.s10.e1" /></sentence><sentence text="" /></document>